HIPAA
Aligned workflows and secure data handling patterns.
AI-Powered CAR-T Therapy Analytics Platform
Move from fragmented updates to decision-grade visibility across trials, therapy pipelines, and launch readiness with an AI-powered CAR-T market intelligence platform built for biopharma strategy teams. CAR-T Navigator delivers real-time CAR-T competitive intelligence, oncology analytics, and pipeline visibility through one unified intelligence layer.
CAR-T Navigator transforms complex clinical and competitive data into actionable insights that support faster strategic decisions across the CAR-T therapy landscape.
Aligned workflows and secure data handling patterns.
Built for pharma-grade reporting and stakeholder confidence.
Near-live updates on trials, assets, and scientific movement.
Signal-first dashboards built for faster strategic decisions.
What CAR-T Navigator Delivers
Track indications, targets, pipeline stages, and global development activity in one unified platform.
Evaluate true opportunity through market sizing, growth forecasts, and clinical performance benchmarks.
Monitor active programs, sponsors, differentiation signals, and competitive intensity over time.
Identify high-potential indications and assess your right to win across selected therapeutic opportunities.
AI Lab
Our AI lab validates real-world strategy hypotheses through rapid iteration, helping life-science teams reduce uncertainty before high-impact decisions.
Read use casesClient Success Stories
CAR-T Navigator is helping strategy, commercial, and R&D teams across the globe make faster, more confident decisions in the rapidly evolving CAR-T landscape.
"CAR-T Navigator helped us connect trial movements to commercial planning faster than our legacy process. The clarity and speed were immediately visible. We've reduced our competitive intelligence gathering time by 60%."
Sarah Chen, Ph.D.
Director, Oncology Strategy | Global Pharma
"The platform's ability to track pipeline progression and competitive positioning in real-time has transformed how we prioritize our BD&L opportunities. It's become an essential tool for our team."
Michael Rodriguez
VP, Business Development | Biotech Leader
Client Retention Rate
Faster Decision Cycle
Active Organizations
Real-time Intelligence Active
250+ trials tracked | Updated 2 min ago
Case Story
Using time-series clinical data, our neural modeling approach supported stronger biomarker discovery — turning raw trial signals into confident, actionable therapy program decisions at unprecedented speed.
Improvement in early-stage target identification accuracy
Faster hypothesis validation vs. conventional methods
Independent trial datasets cross-validated per model run
End-to-end biomarker screening cycle from 14 weeks
Book a walkthrough to see CAR-T Navigator in action.
FAQ
Everything you need to know about CAR-T Navigator before getting started.
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
Join industry leaders leveraging AI-powered intelligence to make confident, data-driven decisions that accelerate breakthrough treatments and technologies to market.